ArticleThe Laryngoscope2026
Risk Analysis Index Versus mFI-5 for Predicting Outcomes After Uvulopalatopharyngoplasty.
Article in The Laryngoscope, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Risk Analysis Index Versus mFI-5 for Predicting Outcomes After Uvulopalatopharyngoplasty.The Laryngoscope · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
OBJECTIVE(S): Current preoperative risk stratification for uvulopalatopharyngoplasty (UPPP) primarily relies on anatomic and disease-severity measures, which do not capture physiologic reserve or vulnerability to postoperative complications. This study aimed to compare the predictive performance of the risk analysis index (RAI) and the modified frailty index-5 (mFI-5) in stratifying postoperative risk among patients undergoing UPPP.
methodsAdult patients who underwent UPPP between 2005 and 2020 were identified. Frailty was assessed, and associations with postoperative complications, length of stay, discharge disposition, and mortality were evaluated. Multivariable regression and receiver operating characteristic analysis were conducted.
resultsA total of 2129 patients were included and severe frailty (RAI > 31) was strongly associated with adverse postoperative outcomes, including Clavien-Dindo (CD) II complications (OR 21.3, 95% CI 3.7-123.8), CD IV (OR 4.6, 95% CI 2.0-10.6), extended length of stay (eLOS) (OR 29.4, 95% CI 5.4-160), non-home discharge (NHD) (OR 6.1, 95% CI 3.0-12.6), and deep surgical site infection (DSSI) (OR 17.5, 95% CI 1.7-176.3) (all p < 0.05). The mFI-5 predicted CD II, eLOS, and NHD but not CD IV or DSSI among severely frail patients (mFI-5 > 3). RAI consistently outperformed mFI-5 across outcomes, including mortality (AUC 0.813 vs. 0.580), CD II (0.784 vs. 0.652), CD IV (0.704 vs. 0.654), eLOS (0.767 vs. 0.669), and NHD (0.767 vs. 0.618).
conclusionAlthough both RAI and mFI-5 are associated with postoperative outcomes following UPPP, RAI provides superior discrimination for mortality and major morbidity. These findings support the incorporation of RAI into preoperative risk stratification for sleep surgery to better inform perioperative planning and resource allocation. LEVEL OF EVIDENCE: 3:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.